 |
市場調查報告書
商品編碼
2077224
In Silico臨床試驗市場：依治療領域、產業、試驗階段及地區分類。In Silico Clinical Trials Market, By Therapeutic Area, By Industry, By Phase, And By Geography |
||||||
價格
簡介目錄
據估計，In Silico臨床試驗市場規模在2026年將達到42.976億美元，預計2033年將達到74.372億美元。預計從2026年到2033年，該市場將以8.2%的複合年成長率成長。
| 分析範圍 | 分析詳情 | ||
|---|---|---|---|
| 基準年 | 2025 | 市場規模（2026 年） | 42.976億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2026-2033 |
| 預測期（2026-2033 年）複合年成長率 | 8.20% | 預計金額（2033 年） | 74.372億美元 |
In Silico臨床試驗是指開發針對特異性患者的模型，創建一個假設的隊列，以檢驗新藥或醫療設備的安全性和有效性。In Silico臨床試驗在評估新藥和醫療設備方面發揮著至關重要的作用。
市場動態：
慢性病、感染疾病和神經系統疾病的日益普遍，醫療設備測試中In Silico模型的日益普及，In Silico臨床試驗數量的不斷增加，以及電腦臨床試驗的高成本效益和試驗中止可能性低，預計將成為推動全球In Silico臨床試驗市場成長的主要因素。
例如，2022年3月，4P-Pharma與資料科學新創公司QuantHealth達成合作協議。 QuantHealth利用基於大量真實世界數據（RWD）和詳細分子層級藥物數據的獨特In Silico模擬方法進行臨床試驗模擬。 4P-Pharma和QuantHealth計劃共同進行各自主要候選藥物的In Silico臨床試驗。此次合作將首先對4P004的II期臨床試驗進行電腦In Silico。 4P004是由4P-Pharma的衍生公司4Moving Biotech開發的First-in-Class骨關節炎治療藥物。
本報告的主要特點
- 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
- 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
- 本節根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數，對全球In Silico臨床試驗市場的主要公司進行介紹。
- 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
- 《全球In Silico臨床試驗市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過分析全球In Silico臨床試驗市場中使用的各種策略矩陣來促進決策。
目錄
第1章：分析目標與假設
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 慢性病、感染疾病和神經系統疾病的高發生率
- 多用途檢測中心短缺
- 在全球範圍In Silico臨床試驗的數量正在增加。
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特五力分析
- 企業合併情景
第4章：全球In Silico臨床試驗市場
- 供給面和需求面分析
- 經濟影響
第5章：全球In Silico臨床試驗市場：依治療領域分類（2021-2033 年）
- 腫瘤學
- 感染疾病
- 循環系統
- 神經病學
- 糖尿病
- 其他治療領域
第6章：全球In Silico臨床試驗市場：按產業分類（2021-2033 年）
- 醫療設備
- 製藥
第7章 全球In Silico臨床試驗市場：依試驗階段分類（2021-2033 年）
- 第一階段
- 第二階段
- 第三階段
- 第四階段
第8章 全球In Silico臨床試驗市場：按地區分類（2021-2033 年）
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東和非洲
第9章 競爭情勢
- Abzena Ltd.
- Clarivate
- Immunetrics Inc.
- GNS Healthcare
- Dassault Systemes
- Evotec
- Novadiscovery
- Insilico Medicine Inc.
- InSilicoTrials Technologies
第10章
- 分析方法
- 關於 Coherent Market Insights
簡介目錄
Product Code: CMI5608
In Silico Clinical Trials Market is estimated to be valued at USD 4,297.6 Mn in 2026 and is expected to reach USD 7,437.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4,297.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.20% | 2033 Value Projection: | USD 7,437.2 Mn |
In silico clinical trials refers to the development of a patient-specific models to form virtual cohorts for testing the safety and efficacy of new drugs and of new medical devices. In silico clinical trials play an important role in the evaluation of new drugs and medical devices.
Market Dynamics:
Increase in prevalence of chronic, infectious, and neurological diseases, increasing use of in silico models to test medical devices, increase in number of in silico clinical trials, and cost-effectiveness and less chances of termination of the trial are major factors expected to propel the growth of the global in silico clinical trials market.
For instance, in March 2022, 4P-Pharma signed a partnership with QuantHealth, a data science start-up taking a unique in-silico approach to clinical trial simulations based on broad real-world data (RWD) and deep molecular drug data. Together, 4P-Pharma and QuantHealth will conduct in silico clinical trials of their lead drug candidates. The partnership will start with in-silico simulation of the phase II clinical trial of 4P004, a first-in-class disease modifying osteoarthritis drug, which is developed by our spin-off, 4Moving Biotech.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global in silico clinical trials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abzena Ltd., Clarivate, Immunetrics Inc., GNS Healthcare, Dassault Systemes, Evotec, Novadiscovery, Insilico Medicine Inc., and InSilicoTrials Technologies, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global in silico clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in silico clinical trials market.
Detailed Segmentation:
- Global In Silico Clinical Trials Market, By Therapeutic Area (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Infectious Disease
- Cardiology
- Neurology
- Diabetes
- Other Therapeutic Areas
- Global In Silico Clinical Trials Market, By Industry (Revenue, USD Mn, 2021 - 2033)
- Medical Devices
- Pharmaceutical
- Global In Silico Clinical Trials Market, By Phase (Revenue, USD Mn, 2021 - 2033)
- Phase I
- Phase II
- Phase III
- Phase IV
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Abzena Ltd.
- Clarivate
- Immunetrics Inc.
- GNS Healthcare
- Dassault Systemes
- Evotec
- Novadiscovery
- Insilico Medicine Inc.
- InSilicoTrials Technologies
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Industry
- Market Snapshot, By Phase
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- High prevalence of chronic, infectious, and neurological diseases
- Unavailability of complex testing centers
- Increase in number of in silico clinical trials worldwide
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Global In Silico Clinical Trials Market
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global In Silico Clinical Trials Market, By Therapeutic Area, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Other Therapeutic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global In Silico Clinical Trials Market, By Industry, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Medical Devices
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Pharmaceutical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global In Silico Clinical Trials Market, By Phase, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Phase I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Phase II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Phase III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Phase IV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
8. Global In Silico Clinical Trials Market, By Geography, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
9. Competitive Landscape
- Abzena Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Clarivate
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Immunetrics Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GNS Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dassault Systemes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novadiscovery
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Insilico Medicine Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- InSilicoTrials Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
In Silico臨床試驗市場規模、佔有率和成長分析（按部署模式、試驗階段、應用、治療領域、最終用戶和地區分類）：產業預測（2026-2033 年）
In Silico臨床試驗市場：2026-2032年全球市場預測（依產品類型、階段、技術平台、應用、治療領域及最終使用者分類）
In Silico臨床試驗市場 - 全球產業規模、佔有率、趨勢、競爭格局、機會及預測（按產業、治療領域、地區和競爭格局分類，2021-2031年）
到 2030 年In Silico臨床試驗市場預測：按類型、模擬類型、治療方法、技術、應用、最終用戶和地區進行的全球分析
In Silico 臨床試驗市場規模、佔有率、趨勢分析報告：按行業、治療領域、階段、地區和細分市場預測，2025-2030 年